Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

PDX vs PSAI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

PSAI Captures Overall Composite Edge (54.8 HOLD vs 45.3 HOLD), While PDX Leads 1–0 on Growth & Valuation Pillars

PSAI Overall Winner 6-Pillar Tally: PDX 1 – 0 PSAI (5 Tie) Matrix Metrics: PDX 1 – 3 PSAI

As of Nov 16, 2026, PSAI (PSAI) captures the overall head-to-head institutional edge over PIMCO Dynamic Income Strategy Fund (PDX) on higher Unified Composite conviction (54.8/100 HOLD vs. 45.3/100 HOLD) after splitting the core matrix 3–1 (led by composite factor balance), while PDX wins 1–0 across the 6-pillar growth and valuation breakdown. PDX trades at $20.06 (N/M Forward P/E, N/A operating margin) versus PSAI at $29.30 (N/M Forward P/E, N/A operating margin).

  • Growth vs. Quality Trade-Off: PSAI earns the overall head-to-head edge with a stronger Unified Composite Score (54.8/100 HOLD vs. PDX 45.3/100 HOLD) and 0.80β · 13% Vol risk profile, whereas PDX leads top-line expansion (N/A YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: PDX is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 40.7); meanwhile PSAI trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 56.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About PDX vs PSAI
PDX NYSE
PIMCO Dynamic Income Strategy Fund
Institutional Equity
$20.06
-0.5% 1D
Market Cap $1.1B
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.19β · 16% Vol
Unified Composite Score
45.3 / 100 HOLD
Tech 41.0 Fund 48.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -2.4%) with fading momentum, RSI 41
RSI-14: 40.7 · SMA20: $20.47 · SMA50: $20.59
PSAI US Equity Head-to-Head Winner
PSAI
Institutional Equity
$29.30
-0.86% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.80β · 13% Vol
Unified Composite Score
54.8 / 100 HOLD
Tech 55.0 Fund 56.0 Flow 50.0 Mom 41.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (1.0% over 20 days), RSI 57
RSI-14: 56.6 · SMA20: $29.16 · SMA50: $28.39

6-Pillar Scorecard Institutional Category Breakdown (PDX 1 – 0 PSAI)

Columns: Metric · PDX · PSAI
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale PDX
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap $1.1B N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Markup
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: PDX (1) vs PSAI (3)
Institutional Metric PDX PSAI Criterion Row Edge
Market Capitalization
Scale
$1.1B N/A Larger Scale PDX
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
42% ($18–$22) 91% ($25–$30) Stronger Trend PSAI
Beta / 30D Volatility
Risk Regime
0.19β · 16% Vol 0.80β · 13% Vol Lower Realized Risk PSAI
Unified Institutional Score
Composite Signal
45.3 / 100 (HOLD) 54.8 / 100 (HOLD) Higher Composite PSAI
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon PSAI +1.71 pp
PDX: +0.2% · PSAI: +1.91%
3M Horizon PSAI +10.5 pp
PDX: -7.69% · PSAI: +2.81%
6M Horizon PSAI +21.95 pp
PDX: -7.13% · PSAI: +14.82%
1Y Horizon PSAI +18.77 pp
PDX: -4.48% · PSAI: +14.29%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PDX vs PSAI. Trailing 12-month operating profitability (PDX N/A vs PSAI N/A) and valuation multiples (PDX N/M vs PSAI N/M Forward P/E) are benchmarked directly in Pillar 4 below.

PDX ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
PSAI ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
PDX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PDX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
PSAI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PSAI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
PDX Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $1.1B market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
PSAI Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ PDX vs PSAI Key Questions & Quantitative Answers

As of Nov 16, 2026, PSAI (PSAI) captures the overall head-to-head institutional edge over PIMCO Dynamic Income Strategy Fund (PDX) on higher Unified Composite conviction (54.8/100 HOLD vs. 45.3/100 HOLD) after splitting the core matrix 3–1 (led by composite factor balance), while PDX wins 1–0 across the 6-pillar growth and valuation breakdown. PDX trades at $20.06 (N/M Forward P/E, N/A operating margin) versus PSAI at $29.30 (N/M Forward P/E, N/A operating margin). Growth vs. Quality Trade-Off: PSAI earns the overall head-to-head edge with a stronger Unified Composite Score (54.8/100 HOLD vs. PDX 45.3/100 HOLD) and 0.80β · 13% Vol risk profile, whereas PDX leads top-line expansion (N/A YoY revenue growth, N/M PEG, and 1 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: PDX is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 40.7); meanwhile PSAI trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 56.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

PDX leads the Growth & Scale pillar: PDX posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with PSAI at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, PDX generates N/A in USD-normalized revenue versus N/A for PSAI. In operating R&D and SG&A reinvestment, PDX deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for PSAI.

PDX and PSAI trade at balanced relative valuation multiples. PDX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas PSAI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PDX (N/A ROE) versus PSAI (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, PDX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.19β · 16% Vol realized risk). By comparison, PSAI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.80β · 13% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.